Enlicitide Chloride for hypercholesterolemia

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 30 Sep 2022: Trial started, NCT06655311
  2. 23 Oct 2024: Trial registered, NCT06655311

The trials

NCT06655311: A Study of Enlicitide Chloride (MK-0616) in Healthy Participants and Participants Taking Statins (MK-0616-012)

State
Completed
Phase
Phase 1
People
56 taking part
Started
30 Sep 2022
Primary completion
2 Jan 2024
Arms
Enlicitide Chloride
Results
None posted
  1. 30 Sep 2022: Trial started
  2. 2 Jan 2024: Trial completed
  3. 23 Oct 2024: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.